Skip to main content
AIM Vaccine Co., Ltd. logo

AIM Vaccine Co., Ltd. — Investor Relations & Filings

Ticker · 6660 HKEX Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2025-04-25 Annual Report
Country HK Hong Kong
Listing HKEX 6660

About AIM Vaccine Co., Ltd.

https://www.aimbio.com

AIM Vaccine Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines for human use. The company's mission is to produce high-quality vaccines to safeguard global health. It holds a leading position among privately-owned vaccine enterprises in its primary market. The core product portfolio includes established vaccines such as Recombinant Hepatitis B Vaccine (Hansenula polymorpha), Inactivated Hepatitis A Vaccine (Human Diploid Cell), and Meningococcal Polysaccharide Vaccine. AIM Vaccine is also a major global supplier of rabies vaccines, committed to leading technological advancements in this area. The company actively expands its pipeline, which features advanced candidates like the 13-valent pneumonia conjugate vaccine and iterative serum-free rabies vaccine, alongside strategic investments in mRNA technology, including an mRNA COVID-19 vaccine candidate.

Recent filings

Filing Released Lang Actions
2024 ANNUAL REPORT
Annual Report Classification · 1% confidence The document is explicitly titled '2024 Annual Report' and contains standard sections such as 'Corporate Information', 'Message from the Chairman', 'Management Discussion and Analysis', and 'Independent Auditor's Report'. It provides comprehensive financial and operational information for the fiscal year 2024, fitting the definition of an Annual Report (10-K). FY 2024
2025-04-25 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is an official announcement under Rule 13.51(1) of the Hong Kong Listing Rules detailing proposed changes to the company’s Articles of Association (its constitutional governance document). It is not the full circular or proxy statement itself but a governance-related announcement of internal rule amendments, fitting the Governance Information category.
2025-04-25 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 1% confidence The document provides the company’s board composition and committee structure, detailing directors’ roles and internal governance arrangements. It does not announce specific appointments or changes (which would be MANG), nor is it simply a report publication notice. This matches the definition of a Governance Information report (CGR).
2025-04-17 English
VOLUNTARY ANNOUNCEMENT - PROPOSED ADOPTION OF SHARE INCENTIVE SCHEME
Share Issue/Capital Change Classification · 1% confidence The document is a voluntary announcement by a Hong Kong-listed company regarding the Board’s proposal to adopt a Share Incentive Scheme under which up to 5% of the Company’s issued shares may be issued as share options or restricted shares. It is not an AGM presentation, earnings release, or management change notice. Rather, it is an announcement of a proposed capital change (new share issue via an employee incentive plan). Therefore, it should be classified under Share Issue/Capital Change (SHA).
2025-04-17 English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF PRESIDENT OF THE GROUP
Board/Management Information Classification · 1% confidence The document is a voluntary announcement on the Hong Kong Exchange regarding the appointment of a new President and related senior management change, clearly indicating a Board/Management Information update. There are no financial statements, voting results, or regulatory filings beyond the management appointment itself. Thus, it falls under the Board/Management Information category.
2025-04-17 English
CHANGE IN COMPOSITION OF BOARD COMMITTEES
Board/Management Information Classification · 1% confidence The document is a formal announcement by AIM Vaccine Co., Ltd. disclosing the resignation of certain directors and the resulting changes in the composition of its board committees (Audit, Nomination, Remuneration and Appraisal, Strategy, Compliance and Risk Control). This clearly falls under announcements of board/management changes rather than financial results, regulatory filings, or AGM materials. Therefore, it should be classified as MANG (Board/Management Information).
2025-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.